mezigdomide (CC-92480) - BMS
ezobresib (BMS-986158) - BMS
Mekinist (trametinib) - Novartis, BeOne Medicines
Tazverik (tazemetostat) - Ipsen
https://clml-25-01.elsevierdigitaledition.com/
 
Luciano J. Costa MD 1; Fredrik Schjesvold MD, PhD 2; Rakesh Popat MBBS, PhD 3; David Siegel MD, PhD 4; Saad Z. Usmani MD 5; Syed Abbas Ali MBBS 6; Michael P. Chu MD 7; Monique A. Hartley-Brown MD 8; Nizar J. Bahlis MD 9; Albert Oriol MD 10; Joaquín Martínez-Lopez MD 11; Enrique M. Ocio MD 12; Karthik Ramasamy MBBS, PhD 13; Donna Reece MD 14; Emma Searle MBChB, PhD 15; Allison Gaudy PhD 16; Antonina Kurtova PhD 16; Wen Zhang PhD 16; Rafael Sarmiento PhD 17; August Dietrich MD 16; Jessica Katz MD, PhD 16; Michael Pourdehnad MD 16; Paul G. Richardson MD 8
 
Aug 26, 2025
 
Next